Sa1014 Bacterial Infections in Cirrhotic Patients in a Tertiary Care Hospital

Lingiah, Vivek; Ding, Cheng; Edula, Raja G Reddy; Bojito-Marrero, Lizza; Ahmad, Maliha; Pyrsopoulos, Nikolaos

doi:10.1016/s0016-5085(15)33436-3

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Diagnosis of other infections were made based on conventional criteria. Any documented evidence of infection, as defined by standard criteria, was included 25 . Gastrointestinal bleeding included evidence of melena, hematemesis, or the documentation of a drop in hemoglobin prompting endoscopic evaluation.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Case–control study: Proton pump inhibitor use is a major risk factor for hepatic encephalopathy after TIPS

2021

View full text Add to dashboard Cite

Summary Background In cirrhotic patients, hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (post‐TIPS HE) is common. Measures that reduce the severity of post‐TIPS HE are limited. Though recent data suggest an association between PPI use and HE, the risk in post‐TIPS HE is not well understood. Aims Examine the risk of post‐TIPS HE associated with differing classes of medications, including proton pump inhibitors (PPI). Methods Between 2012 and 2019, we collected data on known risk factors for post‐TIPS HE as well as medications used. Subjects were classified according to the development of overt hepatic encephalopathy requiring admission. Results In our cohort, admission after TIPS was common, with an average of 7.84 admissions in the post‐TIPS HE group versus 3.76 in the no HE group (P = 0.028). Consistent with previous studies, we found that MELD, grade of encephalopathy, and lower portosystemic gradient were associated with the development of post‐TIPS HE. PPI use prior to TIPS was highly associated with post‐TIPS HE (RR: 4.89, 95% CI: 1.91‐12.50). The risk of post‐TIPS HE was highest 1‐4 weeks post‐procedure but persisted for up to one year after TIPS. Other classes of acid‐suppressive medications, such as histamine receptor blockers (RR: 0.357, 0.154‐0.824) and sucralfate (RR: 0.123, 0.016‐0.924) did not demonstrate this association. Conclusions PPI use is a strong risk factor for the development of post‐TIPS HE. Clinicians should consider the risks and benefits of PPIs in cirrhotic patients undergoing TIPS. Further studies are needed to demonstrate the benefit of discontinuation of PPI, or switching to alternatives.

show abstract

Section: Methodsmentioning

confidence: 99%

“…Any documented evidence of infection, as defined by standard criteria, was included. 25 Gastrointestinal bleeding included evidence of melena, hematemesis, or the documentation of a drop in hemoglobin prompting endoscopic evaluation. Chronic iron deficiency anemia from chronic GI blood loss was not considered an acute gastrointestinal bleed.…”

Section: Me Thodsmentioning

confidence: 99%